Literature DB >> 31149726

Machine Learning Algorithm Identifies Patients at High Risk for Early Complications After Intracranial Tumor Surgery: Registry-Based Cohort Study.

Christiaan H B van Niftrik1,2, Frank van der Wouden3,4, Victor E Staartjes1,2, Jorn Fierstra1,2, Martin N Stienen1,2, Kevin Akeret1,2, Martina Sebök1,2, Tommaso Fedele1,2, Johannes Sarnthein2, Oliver Bozinov1,2, Niklaus Krayenbühl1,2, Luca Regli1,2, Carlo Serra1,2.   

Abstract

INTRODUCTION: Reliable preoperative identification of patients at high risk for early postoperative complications occurring within 24 h (EPC) of intracranial tumor surgery can improve patient safety and postoperative management. Statistical analysis using machine learning algorithms may generate models that predict EPC better than conventional statistical methods.
OBJECTIVE: To train such a model and to assess its predictive ability.
METHODS: This cohort study included patients from an ongoing prospective patient registry at a single tertiary care center with an intracranial tumor that underwent elective neurosurgery between June 2015 and May 2017. EPC were categorized based on the Clavien-Dindo classification score. Conventional statistical methods and different machine learning algorithms were used to predict EPC using preoperatively available patient, clinical, and surgery-related variables. The performance of each model was derived from examining classification performance metrics on an out-of-sample test dataset.
RESULTS: EPC occurred in 174 (26%) of 668 patients included in the analysis. Gradient boosting machine learning algorithms provided the model best predicting the probability of an EPC. The model scored an accuracy of 0.70 (confidence interval [CI] 0.59-0.79) with an area under the curve (AUC) of 0.73 and a sensitivity and specificity of 0.80 (CI 0.58-0.91) and 0.67 (CI 0.53-0.77) on the test set. The conventional statistical model showed inferior predictive power (test set: accuracy: 0.59 (CI 0.47-0.71); AUC: 0.64; sensitivity: 0.76 (CI 0.64-0.85); specificity: 0.53 (CI 0.41-0.64)).
CONCLUSION: Using gradient boosting machine learning algorithms, it was possible to create a prediction model superior to conventional statistical methods. While conventional statistical methods favor patients' characteristics, we found the pathology and surgery-related (histology, anatomical localization, surgical access) variables to be better predictors of EPC.
Copyright © 2019 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Brain tumor; Complication; Machine learning algorithm; Neurocritical care; Neurosurgery; Prediction model

Mesh:

Year:  2019        PMID: 31149726     DOI: 10.1093/neuros/nyz145

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  15 in total

1.  External validation of a prediction model for pain and functional outcome after elective lumbar spinal fusion.

Authors:  Ayesha Quddusi; Hubert A J Eversdijk; Anita M Klukowska; Marlies P de Wispelaere; Julius M Kernbach; Marc L Schröder; Victor E Staartjes
Journal:  Eur Spine J       Date:  2019-10-22       Impact factor: 3.134

Review 2.  Machine Learning in Pituitary Surgery.

Authors:  Vittorio Stumpo; Victor E Staartjes; Luca Regli; Carlo Serra
Journal:  Acta Neurochir Suppl       Date:  2022

3.  Machine Learning and Intracranial Aneurysms: From Detection to Outcome Prediction.

Authors:  Vittorio Stumpo; Victor E Staartjes; Giuseppe Esposito; Carlo Serra; Luca Regli; Alessandro Olivi; Carmelo Lucio Sturiale
Journal:  Acta Neurochir Suppl       Date:  2022

4.  Sex-related differences in postoperative complications following elective craniotomy for intracranial lesions: An observational study.

Authors:  Giovanna Brandi; Vittorio Stumpo; Marco Gilone; Lazar Tosic; Johannes Sarnthein; Victor E Staartjes; Sophie Shih-Yüng Wang; Bas Van Niftrik; Luca Regli; Emanuela Keller; Carlo Serra
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

5.  Development of machine learning models to prognosticate chronic shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Giovanni Muscas; Tommaso Matteuzzi; Eleonora Becattini; Simone Orlandini; Francesca Battista; Antonio Laiso; Sergio Nappini; Nicola Limbucci; Leonardo Renieri; Biagio R Carangelo; Salvatore Mangiafico; Alessandro Della Puppa
Journal:  Acta Neurochir (Wien)       Date:  2020-07-08       Impact factor: 2.216

6.  Easily created prediction model using deep learning software (Prediction One, Sony Network Communications Inc.) for subarachnoid hemorrhage outcomes from small dataset at admission.

Authors:  Masahito Katsuki; Yukinari Kakizawa; Akihiro Nishikawa; Yasunaga Yamamoto; Toshiya Uchiyama
Journal:  Surg Neurol Int       Date:  2020-11-06

7.  Topographic brain tumor anatomy drives seizure risk and enables machine learning based prediction.

Authors:  Kevin Akeret; Vittorio Stumpo; Victor E Staartjes; Flavio Vasella; Julia Velz; Federica Marinoni; Jean-Philippe Dufour; Lukas L Imbach; Luca Regli; Carlo Serra; Niklaus Krayenbühl
Journal:  Neuroimage Clin       Date:  2020-11-19       Impact factor: 4.881

8.  Machine Learning Model for Predicting Acute Respiratory Failure in Individuals With Moderate-to-Severe Traumatic Brain Injury.

Authors:  Rui Na Ma; Yi Xuan He; Fu Ping Bai; Zhi Peng Song; Ming Sheng Chen; Min Li
Journal:  Front Med (Lausanne)       Date:  2021-12-24

9.  Easily Created Prediction Model Using Automated Artificial Intelligence Framework (Prediction One, Sony Network Communications Inc., Tokyo, Japan) for Subarachnoid Hemorrhage Outcomes Treated by Coiling and Delayed Cerebral Ischemia.

Authors:  Masahito Katsuki; Shin Kawamura; Akihito Koh
Journal:  Cureus       Date:  2021-06-16

10.  Machine learning in neurosurgery: a global survey.

Authors:  Victor E Staartjes; Vittorio Stumpo; Julius M Kernbach; Anita M Klukowska; Pravesh S Gadjradj; Marc L Schröder; Anand Veeravagu; Martin N Stienen; Christiaan H B van Niftrik; Carlo Serra; Luca Regli
Journal:  Acta Neurochir (Wien)       Date:  2020-08-18       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.